Key Insights

Highlights

Treatment Research

1 treatments under study, led by A Product Type Of The Modified Commercial Drape Tegaderm R

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Unknown1

Clinical Trials (1)

Showing 1 of 1 trials
NCT01785225Not ApplicableUnknown

Ultrasound-guided Blood Sampling With a Sterile and Dry Puncture Area

Showing all 1 trials

Research Network

Common Treatments

  • A Product Type Of The Modified Commercial Drape Tegaderm R1

Active Sponsors

  • Danish Cancer Society1
  • Aarhus University Hospital1

Top Investigators

Related Conditions

  • Ultrasound1
  • Blood Sampling1

Activity Timeline